Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The pharmacodynamics of a racemic mixture of ketamine R,S(+/-)-ketamine and of each enantiomer, S(+)-ketamine and R(-)-ketamine, were studied in five volunteers. The median frequency of the electroencephalogram (EEG) power spectrum, a continuous noninvasive measure of the degree of central nervous system (CNS) depression (pharmacodynamics), was related to measured serum concentrations of drug (pharmacokinetics). The concentration-effect relationship was described by an inhibitory sigmoid Emax pharmacodynamic model, yielding estimates of both maximal effect (Emax) and sensitivity (IC50) to the racemic and enantiomeric forms of ketamine. R(-)-ketamine was not as effective as R,S(+/-)-ketamine or S(+)-ketamine in causing EEG slowing. The maximal decrease (mean +/- SD) of the median frequency (Emax) for R(-)-ketamine was 4.4 +/- 0.5 Hz and was significantly different from R,S(+/-)-ketamine (7.6 +/- 1.7 Hz) and S(+)-ketamine (8.3 +/- 1.9 Hz). The ketamine serum concentration that caused one-half of the maximal median frequency decrease (IC50) was 1.8 +/- 0.5 micrograms/mL for R(-)-ketamine; 2.0 +/- 0.5 micrograms/mL for R,S(+/-)-ketamine; and 0.8 +/- 0.4 microgram/mL for S(+)-ketamine. Because the maximal effect (Emax) of the R(-)-ketamine was different from that of S(+)-ketamine and R,S(+/-)-ketamine, it was not possible to directly compare the potency (i.e., IC50) of these compounds. Accordingly, a classical agonist/partial-agonist interaction model was examined, using the separ…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The elimination rate of ketamine is nearly equal to that of liver blood flow, with a half-life of approximately two to three hours [20,21].”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [21]
Citations
Cites
Pharmacologic effects of CI‐581, a new dissociative anesthetic, in man
Domino, E. F., Chodoff, P., & Corssen, G. (1965) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196563279 · Cited by 748
Kinetics of pharmacologic response
Holford, N. H. G., & Sheiner, L. B. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90051-1 · Cited by 501
Self-citationEEG Quantitation of Narcotic Effect: The Comparative Pharmacodynamics of Fentanyl and Alfentanil
Scott, J. C., Ponganis, K. V., & Stanski, D. R. (1985) · Anesthesiology · doi:10.1097/00000542-198503000-00005 · Cited by 492
Self-citationPharmacology of Ketamine Isomers in Surgical Patients
White, P. F., Ham, J., Way, W. L., & Trevor, A. (1980) · Anesthesiology · doi:10.1097/00000542-198003000-00008 · Cited by 425
Self-citationCOMPARATIVE PHARMACOLOGY OF THE KETAMINE ISOMERS
WHITE, P. F., SCHÜTTLER, J., SHAFER, A., STANSKI, D. R., HORAI, Y., & TREVOR, A. J. (1985) · British Journal of Anaesthesia · doi:10.1093/bja/57.2.197 · Cited by 415
Self-citationDrill's Pharmacology in Medicine.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-1-148_3 · Cited by 279
Automated EEG Processing for Intraoperative Monitoring: A Comparison of Techniques
Levy, W. J., Shapiro, H. M., Maruchak, G., & Meathe, E. (1980) · Anesthesiology · doi:10.1097/00000542-198009000-00009 · Cited by 222
A Model for Studying Depth of Anesthesia and Acute Tolerance to Thiopental
Hudson, R. J., Stanski, D. R., Saidman, L. J., & Meathe, E. (1983) · Anesthesiology · doi:10.1097/00000542-198310000-00006 · Cited by 165
Self-citationRelationship between the pharmacokinetics and pharmacodynamics of procainamide
Galeazzi, R. L., Benet, L. Z., & Sheiner, L. B. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976203278 · Cited by 153
Self-citationPharmacodynamic modeling of thiopental anesthesia
Stanski, D. R., Hudson, R. J., Homer, T. D., Saidman, L. J., & Meathe, E. (1984) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059279 · Cited by 97
Self-citation
Research works printed but not linked: 3
- M. G. Myers, P. J. Lewis, J. L. Reid, and C. T. Dollery. Cardiovascular effects of centrally administeredd-, l- and dl-propranolol in the conscious rabbit.Eur. J. Clin. Invest. 3:257 (1973).
- H. Stoeckel, H. Schwilden, P. Lauven, and J. Schüttler. EEG parameters for evaluation of depth of anesthesia. In M. D. Vickers and J. Crul (eds.),European Academy of Anaesthesiology Proceedings 1980, Springer, New York, 1981, pp. 73–84.
- J. Schüttler, H. Stoeckel, M. Wilms, H. Schwilden, and P. M. Lauven. Ein pharmakokinetisch begründetes Infusionsmodell für Etomidate zur Aufrechterhaltung von Steady State-Plasmaspiegel.Anaesthesist 29:662–666 (1980).
Cited by
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
“As an anesthetic for humans, (S)-ketamine is reported to be twice as potent as the racemic mixture and approximately three times more potent than (R)-ketamine (White et al., 1985; Schüttler et al., 1987; Himmelseher and Pfenninger, 1998).”
BackgroundKetamine Pharmacology: An Update ( Pharmacodynamics and Molecular Aspects, Recent Findings )
Mion, G., & Villevieille, T. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12099 · Cited by 711
“Ketamine elimination clearance is high (1000–1600 ml/min or 12–20 ml/min/kg), equal to liver blood flow, and then dependent on this flow [5].”
BackgroundKetamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0383-6 · Cited by 672
Ketamine: Teaching an Old Drug New Tricks
Kohrs, R., & Durieux, M. E. (1998) · Anesthesia & Analgesia · doi:10.1097/00000539-199811000-00039 · Cited by 604
Ketamine for chronic pain: risks and benefits
Niesters, M., Martini, C., & Dahan, A. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12094 · Cited by 508
Metadata
- Authors
- Schüttler, J., Stanski, D. R., White, P. F., Trevor, A. J., Horai, Y., Verotta, D., & Sheiner, L. B.
- Affiliations
- United States Department of Veterans Affairs (US)
- Stanford Medicine (US)
- University of California, San Francisco (US)
- University of San Francisco (US)
- Venue
- Journal of Pharmacokinetics and Biopharmaceutics
- Published
- 1987-06
- Volume
- 15
- Issue
- 3
- Pages
- 241-253
- ISSN
- 0090-466X (ISSN-L)
- OpenAlex
- W2027201279
- Cited by
- 178
- References
- 22
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 9 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 6 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 1 · 2013: 8 · 2012: 5
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Pharmacokinetics and Biopharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (2s07rr005353-30)
- National Institute on Aging (AG03104)
- National Institute of Neurological Disorders and Stroke (NS17956)
- National Center for Research Resources (2S07RR5353-20)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- ketamine, enantiomers, esketamine, (R)-ketamine, racemic ketamine, EEG slowing, pharmacodynamic modeling, sigmoid Emax model, central nervous system depression, serum drug concentration, drug potency
- MeSH terms
- Adult, Electroencephalography, Humans, Infusions, Intravenous, Ketamine, Male, Models, Biological, Stereoisomerism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.